From the WAY BACK machine, these “forward-looking statements” from CEO of SCAM CDEX jeffy bumfield. Just letting you know that 2015 is a "break out year" and the G4 Valimed system is due for another re-re-re-launch sometime in what remains of the year, (right). Just think that will be followed by the G5 or whatever in 2016 (right).
Wonder how the whole "opportunities" thing in far off New Zealand and Australia is going? Yeah, RIGHT!
Seven days for the self-ie loan to come due. Wonder if we'll hear the often repeated, "but creditors knew there wasn't any money" so calling the loan was just their way to make SCAM CDEX fail and they knew it! jeffy bumfield was "forced" to file the chapter 7.
In any event the share price is way way way over what it should be....should be about .00001.
As for an update from our Security Markets division, we have continued to sell the ID2 Meth Scanner at a slow and steady pace. With opportunities presenting themselves in New Zealand and Australia, 2015 should prove to be interesting for our Security Markets division. However, until we are able to launch the ValiMed G4 system completely, we will handle the sales of the product as they are needed. We will look to more aggressively market and promote the ID2 Meth Scanner’s product line after the ValiMed G4 product launch.
With the steady flow of inquiries and continued growing interest in the ValiMed G4 system from hospitals nationwide along with the feedback that we have received from various investment banking firms, I am very optimistic that CDEX is ready for a break out year in 2015.
As you probably know, we cannot predict the future with certainty. Many of the thoughts expressed in this letter are “forward-looking statements” under the Private Securities Litigation Reform Act of 1996 and as such are subject to risks and uncertainties. You should read this letter in conjunction with all of our information available on the SEC’s website at www.sec.gov, including risk factors included therein.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.